Propranolol Hydrochloride

• EFFICACY OF PROPRANOLOL IN TRAUMATIC BRAIN INJURY PATIENTS ADMITTED TO THE ICU: A PROSPECTIVE, RANDOMIZED, TRIPLE-BLIND STUDY (ProP TBI in I… Pending
  2025-524194-17-00 Phase III 1 country University Hospital Son Espases
• Withdrawal of neurohormonal therapy in patients with non-ischemic cardiomyopathy, no late gadolinium enhancement, and negative genetic testi… Recruiting
  2025-521780-12-00 Phase III/IV 1 country Andrea Di Marco
• Optimal drug therapy for the suppression of ventricular arrhythmias in Andersen-Tawil syndrome and multifocal ectopic Purkinje-related prema… Recruiting
  2024-510682-42-01 Phase IV 1 country Amsterdam UMC
• Clinical trial to compare the effectiveness of migraine’s preventive treatments in primary care Recruiting
  2024-513597-22-00 Phase IV 1 country Institut Universitari D Investigacio En Atencion Primaria Jordi Gol
• Oral Propranolol for prevention of threshold retinopathy of prematurity Recruiting
  2024-511338-10-01 Phase II 1 country Universitaetsklinikum Tuebingen AöR; Universität Zürich - Klinik für Neonatologi…
• Long-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months … Recruiting
  2022-502332-39-00 Phase II 2 countries Heidelberg University Hospital AöR
• Evaluation of the effectiveness of the reconsolidation therapy in a clinical population suffering from post-traumatic stress disorder Recruiting
  2022-500870-32-02 Phase II 1 country Hopital Erasme
• A phase 2 trial on propranolol in combination with pembrolizumab in advanced Angiosarcoma and Undifferentiated Pleomorphic Sarcoma Recruiting
  2024-513727-16-00 Phase II 3 countries Region Hovedstaden
• Phase 1 study of a Propranolol (HEMANGIOL®) and oral metronomic Vinorelbine (NAVELBINE®) combination on children and teenagers With Refracto… Recruiting
  2024-517185-42-00 Phase I (Other) 1 country Centre Hospitalier Regional De Marseille
• The RIME-IVF study - Investigation of RIsk factors in out-of-hospital-cardiac-arrest patients, and MEdical treatment in Idiopathic Ventricul… Recruiting
  2024-518057-41-00 Phase IV 1 country Rigshospitalet
• Randomized open-label Phase 2 trial evaluating the impact of enhanced versus standard dermatologic management on selected dermatologic adver… Ended
  2023-505863-35-00 Phase II 3 countries Janssen - Cilag International
• Randomized clinical trial assessing the value of Beta-Blockers and Antiplatelet Agents in patients with Spontaneous Coronary Artery Dissecti… Ended
  2024-516039-28-00 Phase IV 1 country Spanish Society Of Cardiology

Showing 1–12 of 12 trials